NO952748D0 - Polypeptid som spesifikt inhiberer Cathepsin L. - Google Patents
Polypeptid som spesifikt inhiberer Cathepsin L.Info
- Publication number
- NO952748D0 NO952748D0 NO952748A NO952748A NO952748D0 NO 952748 D0 NO952748 D0 NO 952748D0 NO 952748 A NO952748 A NO 952748A NO 952748 A NO952748 A NO 952748A NO 952748 D0 NO952748 D0 NO 952748D0
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- cathepsin
- specifically inhibits
- inhibits cathepsin
- specific inhibitor
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 108090000624 Cathepsin L Proteins 0.000 title abstract 3
- 102000004172 Cathepsin L Human genes 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 3
- 102400001321 Cathepsin L Human genes 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 229940078581 Bone resorption inhibitor Drugs 0.000 abstract 1
- 206010039984 Senile osteoporosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28327093 | 1993-11-12 | ||
| JP31353393A JP3276753B2 (ja) | 1993-11-12 | 1993-12-14 | カテプシンｌ特異的阻害ポリペプチド |
| PCT/JP1994/001878 WO1995013302A1 (fr) | 1993-11-12 | 1994-11-08 | Polypeptide a inhibition specifique de la cathepsine l |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952748D0 true NO952748D0 (no) | 1995-07-11 |
| NO952748L NO952748L (no) | 1995-07-11 |
Family
ID=26554960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952748A NO952748L (no) | 1993-11-12 | 1995-07-11 | Polypeptid som spesifikt inhiberer Cathepsin L. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5698519A (de) |
| EP (1) | EP0679659B1 (de) |
| JP (1) | JP3276753B2 (de) |
| KR (1) | KR950704358A (de) |
| AT (1) | ATE178909T1 (de) |
| AU (1) | AU671783B2 (de) |
| CA (1) | CA2151059A1 (de) |
| DE (1) | DE69417872T2 (de) |
| HU (1) | HU214343B (de) |
| NO (1) | NO952748L (de) |
| WO (1) | WO1995013302A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050148504A1 (en) * | 2002-11-29 | 2005-07-07 | Nobuhiko Katunuma | Cysteine protease inhibitor |
| WO2004084830A2 (en) * | 2003-03-21 | 2004-10-07 | Buck Institute | Method for treating alzheimer’s dementia |
| WO2008045017A2 (en) * | 2005-06-22 | 2008-04-17 | Diamond Scott L | Sars and ebola inhibitors and use thereof, and methods for their discovery |
| US20080227688A1 (en) * | 2007-03-13 | 2008-09-18 | Johnston Randal N | Inhibition of viral replication |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3938971A1 (de) * | 1989-11-24 | 1991-05-29 | Biotechnolog Forschung Gmbh | Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat |
-
1993
- 1993-12-14 JP JP31353393A patent/JP3276753B2/ja not_active Expired - Fee Related
-
1994
- 1994-11-08 DE DE69417872T patent/DE69417872T2/de not_active Expired - Fee Related
- 1994-11-08 KR KR1019950702358A patent/KR950704358A/ko active IP Right Grant
- 1994-11-08 EP EP94931695A patent/EP0679659B1/de not_active Expired - Lifetime
- 1994-11-08 AU AU80674/94A patent/AU671783B2/en not_active Ceased
- 1994-11-08 CA CA002151059A patent/CA2151059A1/en not_active Abandoned
- 1994-11-08 WO PCT/JP1994/001878 patent/WO1995013302A1/ja active IP Right Grant
- 1994-11-08 HU HU9501580A patent/HU214343B/hu not_active IP Right Cessation
- 1994-11-08 AT AT94931695T patent/ATE178909T1/de not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/478,520 patent/US5698519A/en not_active Expired - Fee Related
- 1995-07-11 NO NO952748A patent/NO952748L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU214343B (hu) | 1998-03-02 |
| HU9501580D0 (en) | 1995-09-28 |
| NO952748L (no) | 1995-07-11 |
| DE69417872T2 (de) | 1999-08-12 |
| JP3276753B2 (ja) | 2002-04-22 |
| EP0679659A4 (de) | 1996-05-22 |
| DE69417872D1 (en) | 1999-05-20 |
| WO1995013302A1 (fr) | 1995-05-18 |
| CA2151059A1 (en) | 1995-05-18 |
| EP0679659B1 (de) | 1999-04-14 |
| KR950704358A (ko) | 1995-11-20 |
| US5698519A (en) | 1997-12-16 |
| EP0679659A1 (de) | 1995-11-02 |
| JPH07179496A (ja) | 1995-07-18 |
| ATE178909T1 (de) | 1999-04-15 |
| HUT73415A (en) | 1996-07-29 |
| AU671783B2 (en) | 1996-09-05 |
| AU8067494A (en) | 1995-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO923142D0 (no) | Cykliske peptider og anvendelse derav | |
| AU2001290837A1 (en) | Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation | |
| ATE250425T1 (de) | Analoga des parathyroid-hormons | |
| AUPP051497A0 (en) | Antimicrobial peptides | |
| EP0552240A4 (en) | New method of treating depression | |
| SE9101838D0 (sv) | Novel peptides and their use | |
| ATE108178T1 (de) | Dipeptide, verwendbar als pflanzenwachstumsregulatoren. | |
| NO971621L (no) | Keratinocyttvekstfaktoranaloger | |
| NO952748D0 (no) | Polypeptid som spesifikt inhiberer Cathepsin L. | |
| AU1496888A (en) | Biologically active molecules | |
| BR9506038A (pt) | Dna clonato vetor recombinante e planta | |
| ES2146606T3 (es) | Metodo para limpiar alfombras. | |
| NZ511618A (en) | Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X | |
| EP1074264A4 (de) | Inhibitoren für die gefässneubildung | |
| JPS6470500A (en) | Somatostatin analogue compound for treatment | |
| ES2114220T3 (es) | Peptido inhibidor de la fosfolipasa c. | |
| DE69613489D1 (de) | Antibiotische peptide aus der kuhmilch | |
| GB2356864B (en) | Novel polypeptide | |
| ZA929175B (en) | 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes. | |
| KR920700224A (ko) | 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제 | |
| WO2003048187A3 (en) | Peptides and use thereof in therapeutic agents against hiv infection | |
| GB0008504D0 (en) | Novel polypeptide | |
| ES2178911A1 (es) | Peptidos bioactivos derivados de las transferrinas. |